Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Moodys
Cantor Fitzgerald
Medtronic
Daiichi Sankyo
Novartis
Colorcon
Covington
Healthtrust
Accenture

Generated: August 20, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 076368

« Back to Dashboard
NDA 076368 describes POTASSIUM CHLORIDE, which is a drug marketed by Lupin Ltd, Baxter Hlthcare, Abraxis Pharm, Actavis Labs Fl Inc, Hospira, Watson Labs, Kremers Urban Pharms, Lehigh Valley, Fresenius Kabi Usa, Copley Pharm, Pharma Res Software, Gd Searle Llc, Luitpold, Amneal Pharms, Novel Labs Inc, Sigmapharm Labs Llc, Teva, Schering, Tris Pharma Inc, Nesher Pharms, PII, Pharma Serve Ny, Glenmark Pharms Ltd, Mylan Pharms Inc, Intl Medication, Adare Pharms Inc, Lilly, B Braun, Paddock Llc, Anchen Pharms, Akorn, Miles, and Icu Medical Inc, and is included in seventy-six NDAs. It is available from forty-seven suppliers. Additional details are available on the POTASSIUM CHLORIDE profile page.

The generic ingredient in POTASSIUM CHLORIDE is calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate. There are two hundred and sixty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; potassium chloride; sodium chloride; sodium lactate profile page.

Summary for NDA: 076368

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 076368

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL 076368 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7940 0615-7940-05 15 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0615-7940-05)
POTASSIUM CHLORIDE
potassium chloride
TABLET, EXTENDED RELEASE;ORAL 076368 ANDA NCS HealthCare of KY, Inc dba Vangard Labs 0615-7940 0615-7940-30 6 BLISTER PACK in 1 BOX, UNIT-DOSE (0615-7940-30) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrength20MEQ
Approval Date:Aug 18, 2004TE:AB1RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Chubb
Boehringer Ingelheim
Julphar
Baxter
Moodys
Argus Health
Dow
US Department of Justice
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot